TCM
ELV icon

Triumph Capital Management’s Elevance Health ELV Stock Holding History

Triumph Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04K Buy
18
+7
+64% +$2.6K ﹤0.01% 1254
2026
Q1 		$3.27K Hold
11
– – ﹤0.01% 1436
2025
Q4 		$3.9K Buy
+11
New +$3.72K ﹤0.01% 1334

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Triumph Capital Management's ELV Position: Q2 2026 in Review

Triumph Capital Management increased its Elevance Health (ELV) stake by 64% in Q2 2026, buying an estimated $2.6K and bringing the position to 18 shares worth $7.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Triumph Capital Management first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 339 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Triumph Capital Management held 18 shares of Elevance Health worth $7.04K as of Q2 2026.
  • Triumph Capital Management bought 7 Elevance Health shares in Q2 2026, an estimated $2.6K.
  • Elevance Health made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1254 holding.
  • Triumph Capital Management first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 339 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.